Cervical Cancer Clinical Trial
Official title:
Effectiveness of an Individualized Symptom Education Program (ISEP) on the Symptom Distress of Women Receiving Radiation for Gynecological Cancer.
The purpose of this study is to examine whether an Individualized Symptom Education Program
(ISEP) is helpful to women to manage their symptoms when they are receiving radiation
therapy for gynecological cancer.
It is expected that women who participate in the ISEP program will be better able to manage
their symptoms and exprience less distress than women who receive usual care.
Women who have radiation therapy for gynecological cancer may experience a number of
symptoms including fatigue, pain, nausea, pelvic symptoms (urgent and frequent urination and
bowel movements, vaginal discharge, vaginal itching, skin irritation), anxiety and
depression. We know that individualized education programs have helped people with other
types of cancer to better manage their symptoms, and we would like to find out whether such
interventions are helpful to women with gynecological cancers.
This study will compare two types of education: 1) the symptom education program currently
in place (usual care), and 2) an individualized symptom education program (ISEP). This study
is being conducted because we do not know if one type of education in patients who receive
radiation for gynecological cancers is better than the other. Both types of education are
are described below.
Usual care: Usual symptom education during radiation treatment consists of receiving verbal
and written education from a radiation oncologist, nurse and radiation therapist, and other
members of the interdisciplinary team. The radiation therapist will see the patient everyday
during her radiation treatment and her doctor and nurse will see her on a weekly basis. The
patient will also see other members of the team, such as a dietitian and social worker as
required.
Individualized symptom education: Individualized symptom education will include usual
symptom education and also an education program that focuses on symptom management. The
patient will meet with an advanced practice nurse on a weekly basis for six sessions of
about 30 minutes each. The advanced practice nurse will ask about the symptoms the paient is
experiencing and those that are most bothersome to her. She will be given information about
specific strategies to manage those symptoms, including written education materials. These
strategies will be based on published best practice guidelines.
Data on symptom experience will be collected at 3 points: at baseline, after completion of
the education program (end of external beam treatment), and at 3 months following completion
of the education program (3 months following completion of external radiation treatment).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06223308 -
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Terminated |
NCT03367871 -
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT04537156 -
Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 3 | |
| Recruiting |
NCT03668639 -
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT04242199 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
|
Phase 1 | |
| Withdrawn |
NCT04806945 -
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
|
Phase 3 | |
| Active, not recruiting |
NCT04185389 -
Long-Term Follow-Up of HPV FOCAL Participants
|
||
| Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
| Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
| Recruiting |
NCT05107674 -
A Study of NX-1607 in Adults With Advanced Malignancies
|
Phase 1 | |
| Completed |
NCT05120167 -
Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy
|
N/A | |
| Recruiting |
NCT05483491 -
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Completed |
NCT05862844 -
Promise Women Project
|
N/A | |
| Recruiting |
NCT04934982 -
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
|
N/A | |
| Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
| Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
| Completed |
NCT00543543 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
|
Phase 3 | |
| Terminated |
NCT04864782 -
QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04226313 -
Self-sampling for Non-attenders to Cervical Cancer Screening
|
N/A |